BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 30259393)

  • 1. Systematic Review and Meta-analysis of the Prognostic Significance of miRNAs in Melanoma Patients.
    Sabarimurugan S; Madurantakam Royam M; Das A; Das S; K M G; Jayaraj R
    Mol Diagn Ther; 2018 Dec; 22(6):653-669. PubMed ID: 30259393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Investigation of miRNA Biomarkers as Chemoresistance Regulators in Melanoma: A Protocol for Systematic Review and Meta-Analysis.
    Shaw P; Raymond G; Tzou KS; Baxi S; Mani RR; Kumar Govind S; Chandramoorthy HC; Sivanandy P; Rajagopal M; Samiappan S; Krishnan S; Jayaraj R
    Genes (Basel); 2022 Jan; 13(1):. PubMed ID: 35052456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review and meta-analysis of prognostic microRNA biomarkers for survival outcome in nasopharyngeal carcinoma.
    Sabarimurugan S; Kumarasamy C; Baxi S; Devi A; Jayaraj R
    PLoS One; 2019; 14(2):e0209760. PubMed ID: 30735523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Clinical Update on the Prognostic Effect of microRNA Biomarkers for Survival Outcome in Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis.
    Shaw P; Senthilnathan R; Krishnan S; Suresh D; Shetty S; Muthukaliannan GK; Mani RR; Sivanandy P; Chandramoorthy HCK; Gupta MM; Baxi S; Jayaraj R
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503179
    [No Abstract]   [Full Text] [Related]  

  • 5. Prognostic Value of MicroRNAs in Stage II Colorectal Cancer Patients: A Systematic Review and Meta-Analysis.
    Sabarimurugan S; Madhav MR; Kumarasamy C; Gupta A; Baxi S; Krishnan S; Jayaraj R
    Mol Diagn Ther; 2020 Feb; 24(1):15-30. PubMed ID: 32020560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic miRNA classifiers in t cell acute lymphoblastic leukemia: Study protocol for a systematic review and meta-analysis of observational clinical studies.
    Sabarimurugan S; Madurantakam Royam M; Kumarasamy C; Kodiveri Muthukaliannan G; Samiappan S; Jayaraj R
    Medicine (Baltimore); 2019 Mar; 98(9):e14569. PubMed ID: 30817574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Investigation of Chemotherapeutic Resistance and miRNA Expressions in Head and Neck Cancers: A Thorough PRISMA Compliant Systematic Review and Comprehensive Meta-Analysis.
    Jayaraj R; Polpaya K; Kunale M; Kodiveri Muthukaliannan G; Shetty S; Baxi S; Mani RR; Paranjothy C; Purushothaman V; Kayarohanam S; Janakiraman AK; Balaraman AK
    Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553594
    [No Abstract]   [Full Text] [Related]  

  • 8. Circulating MicroRNAs as Prognostic Molecular Biomarkers in Human Head and Neck Cancer: A Systematic Review and Meta-Analysis.
    Lamichhane SR; Thachil T; Gee H; Milic N
    Dis Markers; 2019; 2019():8632018. PubMed ID: 31827646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data.
    Zhang Z; Pan B; Lv S; Ji Z; Wu Q; Lang R; He Q; Zhao X
    Cell Physiol Biochem; 2018; 49(2):678-695. PubMed ID: 30165365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of miRNAs in Head and Neck Cancers: A Comprehensive Systematic and Meta-Analysis.
    Kumarasamy C; Madhav MR; Sabarimurugan S; Krishnan S; Baxi S; Gupta A; Gothandam KM; Jayaraj R
    Cells; 2019 Jul; 8(8):. PubMed ID: 31349668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Significance of miRNAs as a Prognostic Biomarker for Survival Outcome in T Cell - Acute Lymphoblastic Leukemia Patients: A Systematic Review and Meta-Analysis.
    Sabarimurugan S; Kumarasamy C; Royam Madhav M; Samiappan S; Jayaraj R
    Cancer Manag Res; 2020; 12():819-839. PubMed ID: 32104065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and Prognostic Value of miRNAs in Hepatoblastoma: A Systematic Review With Meta-Analysis.
    Wu B; Zhen K; Guo L; Sun C
    Technol Cancer Res Treat; 2022; 21():15330338221087830. PubMed ID: 35532186
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical Theragnostic Relationship between Drug-Resistance Specific miRNA Expressions, Chemotherapeutic Resistance, and Sensitivity in Breast Cancer: A Systematic Review and Meta-Analysis.
    Jayaraj R; Nayagam SG; Kar A; Sathyakumar S; Mohammed H; Smiti M; Sabarimurugan S; Kumarasamy C; Priyadharshini T; Gothandam KM; Ramesh N; Gupta A; Baxi S; Swamiappan S; Krishnan S
    Cells; 2019 Oct; 8(10):. PubMed ID: 31615089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of microRNAs in head and neck cancers: a systematic review and meta-analysis protocol.
    Kumarasamy C; Devi A; Jayaraj R
    Syst Rev; 2018 Oct; 7(1):150. PubMed ID: 30285880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of microRNAs in Predicting the Prognosis of Cervical Cancer Cases: A Systematic Review and Meta-Analysis.
    Sabeena S; Ravishankar N
    Asian Pac J Cancer Prev; 2021 Apr; 22(4):999-1006. PubMed ID: 33906290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNAs as therapeutic predictors and prognostic biomarkers of neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis.
    Zhang Z; Zhang H; Yu J; Xu L; Pang X; Xiang Q; Liu Q; Cui Y
    Breast Cancer Res Treat; 2022 Aug; 194(3):483-505. PubMed ID: 35727379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis.
    Wang Y; Gao X; Wei F; Zhang X; Yu J; Zhao H; Sun Q; Yan F; Yan C; Li H; Ren X
    Gene; 2014 Jan; 533(1):389-97. PubMed ID: 24076132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum-Derived microRNAs as Prognostic Biomarkers in Osteosarcoma: A Meta-Analysis.
    Luo H; Wang P; Ye H; Shi J; Dai L; Wang X; Song C; Zhang J; Li J
    Front Genet; 2020; 11():789. PubMed ID: 32849795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression levels of miR-21 and miR-210 predict unfavorable survival in breast cancer: a systemic review and meta-analysis.
    Tang Y; Zhou X; Ji J; Chen L; Cao J; Luo J; Zhang S
    Int J Biol Markers; 2015 Nov; 30(4):e347-58. PubMed ID: 26349663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of Expression of MicroRNAs in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
    Zhan B; Lu D; Luo P; Wang B
    Clin Lab; 2016 Nov; 62(11):2203-2211. PubMed ID: 28164670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.